All Columns articles
-
OpinionThe clean beauty movement highlights wider challenges in balancing chemical risks and benefits
The ‘clean beauty’ movement exemplifies broader challenges in how we evaluate chemical safety, balancing risks against benefits while avoiding regrettable substitutions.
-
BusinessWill oral weight loss drugs challenge injectables?
Pills may offer convenience for manufacturers, but it’s not clear they will overtake existing drugs
-
OpinionCheap virgin plastic limits recycling potential
Global plastic treaty negotiations risk being derailed by minority opposed to production caps
-
Opinion‘Creative destruction’ in the chemistry lab
Some obsolete lab equipment is quickly replaced, while other items are stubbornly persistent. What modern tech will survive to the 2060s?
-
OpinionIntergovernmental panel on chemicals, waste and pollution needs diverse input
Balancing industrial expertise against unwanted commercial influence is not easy but shouldn’t be discounted
-
OpinionLosing sleep over pesticide exposure
Managing exposure risks poses questions about the extent of producers’ and regulators’ responsibilities for safety
-
OpinionThe atomic weights of most chemical elements aren’t constant
But those values are constantly refined
-
OpinionChina’s drug development charge
Reforms and state support have fuelled domestic and foreign investment in pharmaceutical
-
OpinionChemistry ‘deserts’ threaten to push poorer undergraduates out
Course and departmental closures in the UK are creating ‘cold spots’, leaving students high and dry
-
-
BusinessWill HIV prevention get where it’s needed?
Gilead and its partners’ efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets
-
OpinionGetting good at human tasks
’What do you mean you had to lock the NMR with an oscilloscope and shim the magnet by hand?’
-
OpinionChemistry's capital C
From refinery scale to a nanosecond existence, carbon is everywhere – in life as well as chemistry
-
OpinionCritical metals supply strained
Conflict - both military and political - is having profound effects on supplies of a wide range of materials
-
OpinionThe future of oil refining in the UK
Can plants adapt to be compatible with a lower-carbon environment?
-
OpinionNon-hallucinogenic psychedelics
Chemical insights and advances are contributing to a new therapeutic avenue for mental health conditions
-
OpinionSafety is everyone’s responsibility
Maintaining culture and investment is key, especially in the absence of incidents
-
OpinionIgnoring women’s health shouldn’t be an option
Developing therapies for conditions that predominantly affect women is a neglected, but enormous, opportunity
-
OpinionWomen are not just another confounding factor in drug development
Ignoring physiological differences between the sexes is indefensible
-
OpinionRebuilding pharma supply chains
Multinationals are promising huge US investments, but it’s not all because of Trump’s policies